Perspectives On Real-World Evidence From Expanded Access During COVID-19
VirtualFee waived for Patient Advocates and Students.
Fee waived for Patient Advocates and Students.
We are pleased to announce that our webinar "Where's Our Operation Warp Speed?" has been rescheduled to Tuesday, April 12th from 12-1PM EST. Join us on the 12th to hear from distinguished speakers on this timely and important topic. Please feel free to share the attached flyer, which has the registration link embedded. Registration is free and open to the public. REGISTER HERE: https://www.eventbrite.com/e/wheres-our-operation-warp-speed-tickets-305012138517
The various pathways of preapproval access are confusing, and often misunderstood. CUPA will help bring clarity to this complex topic. About this event Most people access unapproved medical products through clinical trials, but what happens when patients can’t get into a clinical trial, or there is no trial focused on treating their disease? Non-trial…
Hello friends of CUPA, We are excited to announce our upcoming FREE webinar, "Expanded Access Policies and Compliance in an Ever-Changing Environment" taking place on Friday, October 20th from 12-1pm ET via Zoom. This moderated panel will bring together experts from the fields of law, bioethics, patient advocacy, business strategy, and the biopharmaceutical industry to discuss the intent of and compliance with US regulations about expanded…
Mark your calendars! The 3rd biannual CUPA Con will be taking place January 29th and 30th, 2024 in New York City! This will be a hybrid 2-day event, with in-person attendees gaining access to special interactive sessions, networking opportunities, and an evening reception. Full conference agenda and registration link coming soon. We hope to see you there!
Expanded Access 101 - Presented by the Working Group on Compassionate Use & Preapproval Access (CUPA) Date & Time May 15, 2024 12:00 PM Description Our annual introductory webinar covering the basics of the expanded access (compassionate use) pathway of access to investigational medical products